CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
France
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Spain
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Germany
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Switzerland
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
Belgium
14750115.9
Filed on 2016-02-18
14750115.9
Filed on 2016-02-18
CONFORMATIONALLY-STABILIZED RSV PREFUSION F PROTEIN
European Patent
19213895.6
Filed on 2014-07-24
19213895.6
Filed on 2014-07-24
SINGLE-DOMAIN VHH ANTIBODIES DIRECTED TO NOROVIRUS GI.1 AND GII.4 AND THEIR USE
US Patent 11,325,965
Filed on 2020-04-21
Filed on 2020-04-21
DEVELOPMENT OF MUTATIONS USEFUL FOR ATTENUATING DENGUE VIRUSES AND CHIMERIC DENGUE VIRUSES
US Patent 11,318,196
Filed on 2019-11-14
Filed on 2019-11-14
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection
US Patent 11,129,905
Filed on 2019-10-21
Filed on 2019-10-21
Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof
Patent Cooperation Treaty
PCT/US2019/067423
Filed on 2019-12-19
PCT/US2019/067423
Filed on 2019-12-19